Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 6:42 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 409–432 of 1,943 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Context 2 Clear all

Conditions: Overactive Bladder, Overactive Bladder Syndrome, Urinary Urge Incontinence, Urinary Bladder, Overactive, Urinary Incontinence, Urge
Interventions: PTNS, TENS; Device
Lead sponsor: University of New Mexico; Other
Eligibility: 18 Years and older · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Advanced/Metastatic Solid Tumors, Bladder Cancer, Urothelial Carcinoma, Advanced Non-Small Cell Lung Cancer, Carcinoma, Non Small Cell Lung, Carcinoma, Squamous Cell of Head and Neck, Head and Neck Cancer, Esophageal Cancer, Gastroesophageal Junction Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, Pancreatic Adenocarcinoma, Pancreatic Cancer
Interventions: PF-08046876, Pembrolizumab, Cisplatin, Carboplatin; Drug · Combination Product
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older
Enrollment: 540 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 21
States / cities: Duarte, California • Irvine, California • Los Angeles, California + 11 more

Conditions: Essential Tremor, Deep Brain Stimulation
Interventions: Alternating stimulation, Placebo; Other
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years and older
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Bronchiolitis
Interventions: Winix 5500-2 HEPA filtration units; Other
Lead sponsor: IDeA States Pediatric Clinical Trials Network; Network
Eligibility: 1 Week to 12 Months
Enrollment: 230 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 17
States / cities: Anchorage, Alaska • Little Rock, Arkansas • Honolulu, Hawaii + 14 more

Conditions: HIV
Interventions: Lenacapavir long-acting, Standard of Care (SOC); Drug · Other
Lead sponsor: Kelley-Ross & Associates, Inc.; Other
Eligibility: 18 Years and older
Enrollment: 75 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Obesity
Interventions: % COMPX (low ED vs. high ED preload), EAH (low ED vs. high ED snacks); Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 7 Years to 9 Years
Enrollment: 212 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Asthma
Interventions: Mepolizumab, Placebo; Biological · Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 6 Years to 17 Years
Enrollment: 335 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 9
States / cities: Aurora, Colorado • Washington D.C., District of Columbia • Chicago, Illinois + 6 more

Conditions: Obesity
Interventions: Adapted Dietary Guidelines, Adapted Physical Activity Guidelines; Behavioral
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 35 Years to 64 Years
Enrollment: 129 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Health Promotion
Interventions: Fun For Wellness (FFW); Behavioral
Lead sponsor: Michigan State University; Other
Eligibility: 18 Years to 64 Years
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: East Lansing, Michigan

Conditions: Prostate Cancer
Interventions: AMG 509, Abiraterone, Enzalutamide; Drug
Lead sponsor: Amgen; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 479 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2032
U.S. locations: 25
States / cities: Duarte, California • Fullerton, California • San Francisco, California + 22 more

Conditions: Autism Spectrum Disorder
Interventions: Project Search plus ASD Supports; Behavioral
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years to 21 Years
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Weight Loss
Interventions: Get Social, Traditional, Smartphone; Behavioral · Device
Lead sponsor: University of Connecticut; Other
Eligibility: 18 Years to 65 Years
Enrollment: 329 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Storrs, Connecticut

Conditions: Gastro Intestinal Bleeding, Upper Gastrointestinal Bleeding
Interventions: Azithromycin Injection, Metoclopramide Injectable Solution, Sodium chloride 0.9%; Drug
Lead sponsor: Waihong Chung; Other
Eligibility: 18 Years and older
Enrollment: 435 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Concept Mapping Versus Interviews
Interventions: Interviews, Concept Mapping (CM); Other
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 18 Years and older
Enrollment: 148 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Metastatic Non-Small Cell Lung Cancer, NSCLC, Lung Cancer
Interventions: Trilaciclib, Placebo, Docetaxel; Drug
Lead sponsor: G1 Therapeutics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 12
States / cities: Phoenix, Arizona • Los Angeles, California • Rancho Mirage, California + 9 more

Conditions: Brain Injury
Interventions: Goal-oriented attentional self-regulation, Brain Health Education; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 55 Years
Enrollment: 35 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2018
U.S. locations: 1
States / cities: Martinez, California

Conditions: Advanced Gastrointestinal Stromal Tumor (GIST)
Interventions: BGJ398, Imatinib Mesylate; Drug
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 7
States / cities: Boston, Massachusetts • Basking Ridge, New Jersey • Commack, New York + 4 more

Conditions: Breast Cancer, Metastatic Breast Cancer
Interventions: Promoting Resilience in Women with Breast Cancer (PRISM); Behavioral
Lead sponsor: UNC Lineberger Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 2
States / cities: Birmingham, Alabama • Chapel Hill, North Carolina

Conditions: Lung Cancer, Small Cell
Interventions: pazopanib, pemetrexed; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 25
States / cities: Tucson, Arizona • Skokie, Illinois • Indianapolis, Indiana + 19 more

Conditions: Depression, Anxiety, Stress Disorders, Post-Traumatic
Interventions: Life skills and self-defense training; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 21 Years to 65 Years · Female only
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Stanford, California

Conditions: Hypertension
Interventions: Health Literacy-Focused High Blood Pressure Intervention; Behavioral
Lead sponsor: University of Texas at Austin; Other
Eligibility: 60 Years and older
Enrollment: 360 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Ellicott City, Maryland

Conditions: Schizophrenia, Bipolar Disorder
Interventions: CReSSmicro handheld topography device; Device
Lead sponsor: University of Medicine and Dentistry of New Jersey; Other
Eligibility: 18 Years to 75 Years
Enrollment: 276 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2010
U.S. locations: 1
States / cities: New Brunswick, New Jersey

Conditions: Traumatic Brain Injury
Interventions: Constraint-Induced Movement Therapy (CIMT), Lakeshore Enriched Fitness Training (LEFT), standard Transfer Package (sTP), enhanced Transfer Package (eTP); Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years to 90 Years
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Dyspnea, Lactic Acidosis, Muscle, Breathlessness, Exercise, Recovery
Interventions: High Velocity Therapy; Device
Lead sponsor: Vapotherm, Inc.; Industry
Eligibility: 18 Years to 30 Years
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: Auburn, Alabama

Search by objective public record fields.

INvestigation of TENS Efficacy Versus Posterior Tibial Nerve Stimulation for Overactive Bladder

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

The Effectiveness of Alternating Stimulation in Preventing Tolerance in Essential Tremor Patients

Bronchiolitis Recovery and the Use of High Efficiency Particulate Air (HEPA) Filters

Implementation and Deliver of Lenacapavir for PrEP in a Community Pharmacy Setting

Eating Phenotypes for Childhood Obesity in the Context of Familial Obesity Risk

A Trial of Mepolizumab Adjunctive Therapy for the Prevention of Asthma Exacerbations in Urban Children

Steps Ahead, Adapting Physical Activity Guidelines for the Lower Mississippi Delta Population

Team Science to Promote Physical Activity

Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

Effect of a 9-Month Internship Intervention for Military Dependents With ASD

Get Social: Randomized Trial of a Social Network Delivered Lifestyle Intervention

Metoclopramide, Azithromycin, or Nondrug Pretreatment for UGIB to Reduce Second Endoscopy

Concept Mapping as a Scalable Method for Identifying Patient-Important Outcomes

Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Docetaxel for Metastatic Non-Small Cell Lung Cancer (NSCLC) (PRESERVE 4)

Neural Bases of Cognitive Rehabilitation for Brain Injury

BGJ398 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST)

Promoting Resilience in Women With Breast Cancer (PRISM -MBC)

A Study to Evaluate Pazopanib in Comparison to Pemetrexed in Maintenance Setting in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) Population

Self-Defense Training in Women With Trauma

Health Literacy-Focused Program to Improve Blood Pressure Control in Korean Americans

Measuring Smoking Behavior in People With Schizophrenia and Bipolar Disorder

The Brave Initiative: Bringing Rehabilitation to American Veterans in an Enriched Environment

Effect of High Velocity/Hyperoxic Breathing Therapy on Blood Lactate Decline